ProAssurance (PRA) opened 2026 with Q1 total revenue of US$262.6 million and basic EPS of US$0.16, while on a trailing twelve month basis revenue stood at US$1.1 billion with basic EPS of US$1.27. Over the past year, the company has seen trailing twelve month net income move from US$52.7 million in Q4 2024 to US$65.2 million in Q1 2026, with trailing net profit margins at 5.9% versus 3.7% a year earlier. This highlights a period of margin improvement that provides context for the latest earnings report.

See our full analysis for ProAssurance.

With the headline numbers on the table, the next step is to see how this mix of stronger recent profitability and softer forecast growth compares with the prevailing narratives that investors follow.

Trailing EPS And Margin Trend Stand Out

• On a trailing twelve month basis, basic EPS is US$1.27 and net income is US$65.2 million on US$1.1b of revenue. That lines up with a net margin of 5.9% compared with 3.7% a year earlier and earnings growth of 54.1% over that period.
• Bulls argue that improving profitability and five year annualized earnings growth of 9.3% can support a stronger long term story. However, the data here also show trailing revenue easing from US$1.14b in early 2025 to US$1.10b in Q1 2026, which means the bullish view leans heavily on margin gains rather than top line momentum.

To see how supporters of the bullish view connect these margin trends to their long term thesis on ProAssurance, take a look at the 🐂 ProAssurance Bull Case.

Quarterly Volatility Versus Bearish Concerns

• Q1 2026 basic EPS of US$0.16 sits between recent extremes, such as a small loss in Q1 2025 and US$0.65 in Q4 2025. Quarterly net income has ranged from a loss of US$5.8 million in Q1 2025 to US$33.4 million in Q4 2025 before landing at US$8.5 million in the latest quarter.
• Bears highlight risks from higher claims severity and aggressive competition. Even so, the trailing twelve month figures show earnings of US$65.2 million and a 5.9% margin compared with 3.7% a year earlier, so the bearish view is really focused on whether that profitability can hold up if the recent swings in quarterly EPS and combined ratios, which reached 115.6% in Q1 2025 and 114.7% in Q3 2025, reappear.

Skeptics pointing to those swings may want to see how the more cautious camp frames these risks in the 🐻 ProAssurance Bear Case.

Premium Valuation Versus Forecast Declines

• The stock trades on a trailing P/E of 19.4x, compared with 8.5x for peers and 11.5x for the US Insurance industry. The current share price of US$24.60 sits not far below the most bullish analyst price target of US$25.00, even as forecasts point to revenue declining about 3.8% a year and earnings about 4.8% a year over the next three years.
• What stands out for the bearish narrative is the tension between that premium P/E and the expectation of declining revenue and earnings. The recent 54.1% trailing earnings growth and margin improvement need to be weighed carefully against projections that do not point to continued growth, especially when the share price is already close to the upper end of the analyst target range at US$25.00.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for ProAssurance on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed signals in the story so far, with stronger recent margins on one side and cautious forecasts on the other, mean it is worth checking the numbers directly and deciding where you stand. Start with the 1 key reward and 1 important warning sign.

Explore Alternatives

ProAssurance combines richer quarterly volatility and forecast revenue and earnings declines with a premium P/E and a share price already near the top analyst target.

If that mix of softer projections and a full looking valuation feels tight, it is worth checking whether other companies look better priced through the 44 high quality undervalued stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.